web analytics
25 C
Munich
Thursday, August 11, 2022

Stock Spotlight is SPO Global and Gerpang Healthcare Group (OTCMKTS: SPOM)

SPO Global and Gerpang Healthcare Group (OTCMKTS: SPOM) has emerged as one of the biggest runners in small caps in recent days skyrocketing off its $0.011 lows to recent highs of $0.68 per share. The stock has transformed from thinly traded to one of the top most traded stocks in small caps.

There is plenty to get excited about on SPOM – the Company just closed on the merger with Gerpang Healthcare Group of Shandong, China which has a staff of over 220 people, more than 10 international and national patents, and an annual turnover of approximately RMB 1 billion.

SPO Global (OTCMKTS: SPOM) is a diversified holding company whose strategy is to acquire interests in a range of profitable ventures. Gerpang Healthcare Group (www.gerpanghealthcare.com), is located in Jinan Pharma Valley Industrial Park, High-tech District. It is an innovative technology-based private and high-tech enterprise. The main business scope of the Gerpang includes bio-pharmaceutical R&D, development and sales of medical information software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, medicine and agents, as well as sales of medical equipment supplies. In addition to having a staff of over 220 people, Gerpang has more than 10 international and national patents and its annual turnover is approximately RMB 1 billion.

In the past five years, Gerpang has established strategic partnerships with various universities in biomedicine in Toronto, Montreal, Boston, New York and Connecticut, and has established a wide range of government resource management and business contacts. The relationships have resulted in multi-level investments by Gerpang in more than 20 projects.

To Find out the inside Scoop on SPOM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

SPOM

On February 19 SPOM said it has completed its previously announced merger with Gerpang Healthcare Group (“Gerpang”) of Shandong, China. The acquisition closed on February 19, 2020, and, as previously discussed, all officers and directors of SPO Global have been replaced by the management of Gerpang. Mr. Lu Fengyou has been appointed CEO and Mr. Liangjian Peng has been appointed Secretary. Mr. Fengyou Lu, the CEO and founder of Gerpang Healthcare Group, has 24 years of business experience in the pharmaceutical market in the Greater China region and has successfully run four foreign-funded enterprises and large private enterprises. He is also a Chairman of Pioneer Zhongrun Biotechnology Co., Ltd. and CEO of Canada SOTA Biomedical Investment Co., Ltd. Mr. Lu is a strategic partner of Pioneer Zhongrun (Beijing) Stroke International Specialist Hospital. Previously, Mr. Lu was a Professor of the School of Pharmaceutical Science of Shandong University.

Gerpang Healthcare Group is located in Jinan Pharma Valley Industrial Park, High-tech District. It is an innovative technology-based private and high-tech enterprise. The main business scope of Gerpang includes bio-pharmaceutical R&D, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplement, medicine, as well as agents and sales of medical equipment supplies. Gerpang has a staff of over 220 people, more than 10 international and national patents, and an annual turnover of approximately RMB 1 billion.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at an $11.5 million market valuation SPOM is an exciting story developing in small caps – SPOM just closed on the merger with Gerpang Healthcare Group of Shandong, China which has a staff of over 220 people, more than 10 international and national patents, and an annual turnover of approximately RMB 1 billion. SPOM is quickly developing a loyal shareholder base that continues to bid SPOM higher. We will be updating on SPOM on a daily basis so make sure you are subscribed to microcapdaily.com so you know what is going on with SPOM.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in SPOM either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.